CytomX Therapeutics, Inc. ($CTMX)
Ogden Christopher โ Chief Financial Officer
Shares
19,323
Price
$6.42
Total Value
$124,111.63
Nearby Earnings
Mar 5, 2026
EPS:Est: -0.08
Revenue:Est: $7.33M
Mar 16, 2026
EPS:-0.22 (est: -0.09)+135.7%
Revenue:$663.00K (est: $6.28M)-89.4%
Transaction Details
| Insider | Ogden Christopher |
|---|---|
| Title | Chief Financial Officer |
| Transaction Date | Mar 17, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Mar 19, 2026 |
| Shares Sold | 19,323 |
| Price per Share | $6.42 |
| Total Value | $124,111.63 |
| Shares Owned After | 296,948 |
| Derivative | No |
| Accession Number | 0001610717-26-000122 |
| Document | View SEC Filing |